Paper - WANFANG MED ONLINE

You Position: Home > Paper

Liver diseases and thyroid functional status

( views:26, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 28

DOI:: 10.11569/wcjd.v25.28.2503

Key Word:: 肝功能异常;甲状腺功能异常;丙型肝炎病毒;干扰素α;抗甲状腺药物;Abnormal liver function;Abnormal thyroid function;Hepatitis C virus;Interferon alpha;Antithyroid drugs

Abstract： The liver is closely related to the thyroid function.On one hand,many liver diseases can cause abnormal thyroid function,such as hepatitis B virus (HBV) infection,hepatitis C virus (HCV) infection,liver cirrhosis,and nonalcoholic fatty liver disease.Thyroid dysfunction is also commonly caused by interferon alpha treatment for anti-HBV or HCV therapy.On the other hand,thyroid diseases such as hyperthyroidism or hypothyroidism can result in abnormal liver function.In addition,liver injury can also be frequently caused by antithyroid drugs or levothyroxine of over conventional doses.The causal relationship between abnormal liver function and thyroid dysfunction remains unclear.

Reference

[1]赵艳娟,叶春艳,宋效丹.急性乙型肝炎患者血清甲状腺激素水平变化[J].2011,(2).
[2]马永华,刘志斌,师廷梅.肝硬化严重程度与甲状腺激素水平相关关系[J].2013,(1).
[3]胡晖,张阳德,邓豪余,等.131I结合人工肝支持系统治疗甲亢合并重型肝炎[J].2006,(2).
[4]王文,闻颖,刘沛.乙肝病毒感染相关的Graves病、糖尿病1例[J].2011,(1).
[5]罗欣.肝硬化严重程度与甲状腺素水平、肝纤维化指标及血清糖链抗原125相关性分析[J].2014,(2).
[6]赵家军.甲状腺疾病与肝脏[J].2014,(3).
[7]陈学福,陈小苹,马晓军,等.聚乙二醇干扰素α治疗慢性乙型肝炎诱发甲状腺疾病的临床研究[J].2012,(2).
[8]张爱民,陈铿,谭行华,等.聚乙二醇干扰素α-2a治疗慢性乙型肝炎引起甲状腺功能异常临床分析[J].2012,(3).
[9]Nathalie Ganne-Carrie,Abdelkrim Medini,Emmanuelle Coderc,etc.Latent Autoimmune Thyroiditis in Untreated Patients with HCV Chronic Hepatitis: a Case-control Study[J].2000,14(2).
[10].Propylthiouracil-induced liver failure and artificial liver support systems: a case report and review of the literature.[J].2017,13.
[11]Miao M,Li Y,Xu C,etc.Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese.[J].2011,75(2).
[12]Y, Tomer,T F, Davies.Infection, thyroid disease, and autoimmunity.[J].1993,14(1).
[13].Serum Total Triiodothyronine versus Free Tetraiodothyronine and TSH in Patients with HCV Related Cirrhosis and Their Correlation to the Severity of Cirrhosis[J].2016.
[14]Alessandro Antonelli,Clodoveo Ferri,Alessandro Pampana,etc.Thyroid disorders in chronic hepatitis C[J].2004,117(1).
[15]Suzuki K,Dohan O,Rose NR,etc.Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid.[J].2000,97(4).
[16]T, Kano,T, Kojima,T, Takahashi,etc.Serum thyroid hormone levels in patients with fulminant hepatitis: usefulness of rT3 and the rT3/T3 ratio as prognostic indices.[J].1987,22.
[17]Ferrannini E,Fallahi P,Antonelli A,etc.Thyroid disorders in chronic hepatitis C virus infection.[J].2006,16(6).
[18]Zhang, Ren-Wen,Shao, Cui-Ping,Huo, Na,etc.Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10[J].2015,21(33).
[19]Chopra IJ.Clinical review 86: Euthyroid sick syndrome: is it a misnomer?[J].1997,82(2).
[20]Kang, Shino,Amino, Nobuyuki,Kudo, Takumi,etc.Occurrence of thyroxine tablet (Thyradin S (R)) - induced liver dysfunction in a patient with subclinical hypothyroidism[J].2015,62(8).
[21]Zambrini,H.,Chammas,M.C.,Danilovic,D.L.S.,etc.Thyroid disturbance related to chronic hepatitis C infection: Role of CXCL10[J].2013,60(5).
[22]Guoli, Liu,Xiao, Zheng,Liying, Guan,etc.Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.[J].2015,40.
[23]Toubi E,Rosner I,Kessel A,etc.Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.[J].2006,27(2).
[24]Anne C Desbois,Patrice Cacoub,Cloe Comarmond,etc.Extrahepatic manifestations of chronic hepatitis C virus infection.[J].2016,3(1).
[25]Rendong, Zheng,Kemian, Liu,Kun, Chen,etc.Lithium Carbonate in the Treatment of Graves' Disease with ATD-Induced Hepatic Injury or Leukopenia.[J].2015,2015.
[26]Bano, Arjola,Chaker, Layal,Plompen, Elisabeth P. C.,etc.Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study[J].2016,101(8).
[27]Arata N,Davies TF,Ando T,etc.By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse.[J].2006,121(1).
[28]Fatma Yahyao?lu, G?kmen,Süleyman, Ahbab,Hayriye Esra, Atao?lu,etc.FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.[J].2016.
[29]Albert J. Czaja,Herschel A. Carpenter,Paula J. Santrach,etc.Immunologic features and HLA associations in chronic viral hepatitis[J].1995,108(1).
[30]Renfei, Wang,Jian, Tan,Guizhi, Zhang,etc.Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.[J].2017,96(5).
[31]Fariborz, Mansour-Ghanaei,Mojtaba, Mehrdad,Sahereh, Mortazavi,etc.Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage.[J].1900,11(5).
[32]Seyed Mohsen, Dehghani,Mahmood, Haghighat,Fatemeh, Eghbali,etc.Thyroid hormone levels in children with liver cirrhosis awaiting a liver transplant.[J].2013,11(2).
[33]van den Berg, Eline H.,van Tienhoven-Wind, Lynnda J. N.,Amini, Marzyeh,etc.Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study[J].2017,67.
[34]Albert Tran,Jean François Quaranta,Sylvia Benzaken,etc.High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy[J].1993,18(2).
[35]Quadros P,Garcia-Sancho L,Carreno V,etc.Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection.[J].2008,80(9).
[36]尹凤荣.以肝功能异常为主要表现的甲状腺功能减退4例临床分析[J].2014,(5).
[37]Yichen, Wu,Shaoli, You,Hong, Zang,etc.Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure.[J].1900,14(2).